January 2025

Mountainfield Venture Partners, a biopharmaceutical company creation firm, partners with Keymed Biosciences to form Timberlyne Therapeutics, accessing global development and commercial rights outside of greater China for CM313 Financing co-led by Abingworth, Bain Capital Life Sciences, and Venrock H

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: